Avensis Exim Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 21-06-2024
- Paid Up Capital ₹ 0.10 M
as on 21-06-2024
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -2.98%
(FY 2022)
- Profit -340.61%
(FY 2022)
- Ebitda -288.07%
(FY 2022)
- Net Worth -6.04%
(FY 2022)
- Total Assets 2.66%
(FY 2022)
About Avensis Exim
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jagdishbhai Desai and Sanjaykumar Jha serve as directors at the Company.
- CIN/LLPIN
U51109GJ2009PTC056485
- Company No.
056485
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Avensis Exim?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jagdishbhai Desai  | Director | 31-Mar-2009 | Current |
| Sanjaykumar Jha | Director | 31-Mar-2009 | Current |
Financial Performance of Avensis Exim.
Avensis Exim Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 2.98% decrease. The company also saw a substantial fall in profitability, with a 340.61% decrease in profit. The company's net worth dipped by a decrease of 6.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Avensis Exim?
In 2021, Avensis Exim had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Expert Second Opinion Services Private LimitedActive 3 years 2 monthsSanjaykumar Jha is a mutual person
Cuidado Medico Private LimitedActive 15 years 11 monthsJagdishbhai Desai and Sanjaykumar Jha are mutual person
Salvavita Pharmaceuticals Private LimitedActive 3 years 11 monthsSanjaykumar Jha is a mutual person
Avensis Pharmaceuticals Private LimitedActive 10 years 9 monthsJagdishbhai Desai and Sanjaykumar Jha are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Avensis Exim?
Unlock and access historical data on people associated with Avensis Exim, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Avensis Exim, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avensis Exim's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
